Analysts Offer Insights on Healthcare Companies: Centene (CNC) and Eli Lilly & Co (LLY)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Centene (CNC) and Eli Lilly & Co (LLY) with bullish sentiments.

Centene (CNC)

In a report released today, Michael Wiederhorn from Oppenheimer assigned a Buy rating to Centene, with a price target of $90.00. The company’s shares closed last Monday at $66.00.

According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 24.0% and a 77.3% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as The Ensign Group, Community Health, and HCA Healthcare.

Currently, the analyst consensus on Centene is a Moderate Buy with an average price target of $76.00.

See today’s analyst top recommended stocks >>

Eli Lilly & Co (LLY)

Mizuho Securities analyst Vamil Divan maintained a Buy rating on Eli Lilly & Co today and set a price target of $228.00. The company’s shares closed last Monday at $187.22.

According to TipRanks.com, Divan is a 1-star analyst with an average return of -1.2% and a 49.2% success rate. Divan covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Satsuma Pharmaceuticals, and ACADIA Pharmaceuticals.

Eli Lilly & Co has an analyst consensus of Strong Buy, with a price target consensus of $232.30.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on LLY:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts